gvtcx

Purchase of Fibroscan standalone liver elastography machine

Chelsea & Westminster Hospital NHS Foundation Trusts Published 16 Jul 2020 Contracts Finder

key details

Value£100,000
Statuscomplete
Category (CPV) 33000000
Deadline16 Jun 2020
Contract start1 Jul 2020
Contract end30 Jun 2025
SME suitableNo
OCIDocds-b5fd17-19b43008-2c77-43f8-927e-6e2475d12f17

Award

SupplierValueDateStatus
Echosens UK Ltd £100,000 29 Jun 2020 active

description

The Trust required to purchase new standalone liver elastography machine.

The 'Fibroscan' is now the gold standard method to assess the degree of liver fibrosis in patients without the need for a biopsy and is used in clinical practice guidelines (including NICE) for many disorders such as Hepatitis B, Hepatitis C and Non-alcoholic fatty liver disease (NAFLD). In recent years, the number of patients being seen in the liver clinic with NAFLD has increased dramatically. This is most commonly related to being overweight. Patients with NAFLD are not only at risk of developing liver fibrosis but also are at risk of heart attacks, strokes and diabetes. The new Fibroscan machines are able to measure the amount of fat within the liver with the CAP score (controlled attenuation parameter) to diagnose this without the need for biopsy. The standard 'M-probe' that the Fibroscan uses is often unable to take an accurate reading in patients who are very overweight. In these cases, the new 'XL-probe' is required to take the Fibroscan measurements.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
16 Jul 2020 Award (award) · cccf863c-cc1a-4315-a283-5cf37abd93b1-370913

more from Chelsea & Westminster Hospital NHS Foundation Trusts

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.